Stalfort John A Iii Insider Trades

Insider Trading History

Track insider trading activity for Stalfort John A Iii. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acumen Pharmaceuticals
Acumen Pharmaceuticals ABOS
Director
Holding Value $424k 185,124 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.9k 19,500 shares
$1.07
$2.29
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $6.8M 1,155,224 shares
Last Trade
Jun 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$316k 113,246 shares
$2.79
$5.89
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $11.5M 1,873,800 shares
Last Trade
Nov 26, 2024 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$55.5k 50,000 shares
$1.11
$6.15
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $11.2M 1,823,800 shares
Last Trade
Nov 22, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.12M 1,123,595 shares
$0.99
$6.15
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $3.46M 561,797 shares
Last Trade
Nov 22, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$559k 561,797 shares
$0.99
$6.15
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $3.46M 561,797 shares
Last Trade
Nov 22, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$601k 561,797 shares
$1.07
$6.15
Acumen Pharmaceuticals
Acumen Pharmaceuticals ABOS
Director
Holding Value $57.3k 25,000 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$65.5k 25,000 shares
$2.62
$2.29
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $6.47M 1,098,601 shares
Last Trade
May 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$312k 98,440 shares
$3.17
$5.89
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $5.89M 999,381 shares
Last Trade
Aug 16, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$751k 388,889 shares
$1.93
$5.89
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $6.18M 1,049,381 shares
Last Trade
Aug 16, 2023 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$96.5k 50,000 shares
$1.93
$5.89
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $258k 43,800 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.5k 43,800 shares
$0.72
$5.89
Acumen Pharmaceuticals
Acumen Pharmaceuticals ABOS
Director
Holding Value $57.3k 25,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$130k 25,000 shares
$5.20
$2.29
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $4.31M 700,205 shares
Last Trade
Jul 05, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$595k 238,095 shares
$2.50
$6.15
Acumen Pharmaceuticals
Acumen Pharmaceuticals ABOS
Director
Holding Value $57.3k 25,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.8k 25,000 shares
$3.59
$2.29
Acumen Pharmaceuticals
Acumen Pharmaceuticals ABOS
Director
Holding Value $395k 172,324 shares
Last Trade
Jul 06, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$707k 35,000 shares
$20.20
$2.29
Acumen Pharmaceuticals
Acumen Pharmaceuticals ABOS
Director
Holding Value $0 0 shares
Last Trade
Jun 30, 2021 Sale
No data
No data
$2.29
Acumen Pharmaceuticals
Acumen Pharmaceuticals ABOS
Director
Holding Value $77.9k 34,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$2.29

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up